171 related articles for article (PubMed ID: 37601073)
1. Gentiopicroside modulates glucose homeostasis in high-fat-diet and streptozotocin-induced type 2 diabetic mice.
Wang X; Long D; Hu X; Guo N
Front Pharmacol; 2023; 14():1172360. PubMed ID: 37601073
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
4. Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.
Xiao H; Sun X; Lin Z; Yang Y; Zhang M; Xu Z; Liu P; Liu Z; Huang H
Acta Pharm Sin B; 2022 Jun; 12(6):2887-2904. PubMed ID: 35755276
[TBL] [Abstract][Full Text] [Related]
5. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
Liu Y; Deng J; Fan D
Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
[TBL] [Abstract][Full Text] [Related]
7. Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation.
Zhu YX; Hu HQ; Zuo ML; Mao L; Song GL; Li TM; Dong LC; Yang ZB; Ali Sheikh MS
Biomed Rep; 2021 Jul; 15(1):56. PubMed ID: 34007449
[TBL] [Abstract][Full Text] [Related]
8. Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM.
Chen D; Chen X; He C; Xiao C; Chen Z; Chen Q; Chen J; Bo H
J Ethnopharmacol; 2023 Apr; 306():116162. PubMed ID: 36646159
[TBL] [Abstract][Full Text] [Related]
9. Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway.
Yang SQ; Chen YD; Li H; Hui X; Gao WY
Arch Med Res; 2018 Jul; 49(5):314-322. PubMed ID: 30409503
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
[TBL] [Abstract][Full Text] [Related]
11. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
Liang M; Wang L; Wang W
Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
13. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
14. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
15. Gentiopicroside alleviates cardiac inflammation and fibrosis in T2DM rats through targeting Smad3 phosphorylation.
Zou XZ; Zhang YW; Pan ZF; Hu XP; Xu YN; Huang ZJ; Sun ZY; Yuan MN; Shi JN; Huang P; Liu T
Phytomedicine; 2022 Nov; 106():154389. PubMed ID: 36037771
[TBL] [Abstract][Full Text] [Related]
16. Surfactin Mitigates a High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes through Improving Pancreatic Dysfunction and Inhibiting Inflammatory Response.
Chen X; Zhao H; Lu Y; Liu H; Meng F; Lu Z; Lu Y
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232419
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota.
Lee YS; Lee D; Park GS; Ko SH; Park J; Lee YK; Kang J
Food Funct; 2021 Jul; 12(14):6363-6373. PubMed ID: 34105563
[TBL] [Abstract][Full Text] [Related]
19. Puerarin suppresses the hepatic gluconeogenesis via activation of PI3K/Akt signaling pathway in diabetic rats and HepG
Liu Y; Qiu Y; Chen Q; Han X; Cai M; Hao L
Biomed Pharmacother; 2021 May; 137():111325. PubMed ID: 33761593
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ
Chem Biol Interact; 2015 Jan; 225():70-9. PubMed ID: 25446853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
